Zimmer Biomet Holdings ZBH Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$68.8M+4.3% | -$71.9M+4.6% | -$75.4M+4.9% | -$79.3M-19.8% | -$66.2M-6.9% | ||
| $2.09B-7.0% | $2.24B+12.1% | $2B-3.7% | $2.08B+8.8% | $1.91B-5.6% | ||
| $576.2M-27.3% | $792.4M+41.7% | $559.3M-5.6% | $592.2M+7.7% | $549.8M-6.3% | ||
| $1.51B+4.1% | $1.45B+0.6% | $1.44B-2.9% | $1.49B+9.3% | $1.36B-5.4% | ||
| 72.4%+7.7pp | 64.7%-7.4pp | 72.1%+0.6pp | 71.5%+0.3pp | 71.2%+0.2pp | ||
| $103.4M-12.9% | $118.7M+2.4% | $115.9M+2.3% | $113.3M+2.4% | $110.6M+1.9% | ||
| $849.9M-2.6% | $872.3M+7.5% | $811.4M-0.4% | $814.8M+7.4% | $758.8M+1.6% | ||
| $162.1M-8.8% | $177.7M+0.7% | $176.5M+9.9% | $160.6M+6.4% | $151M-4.2% | ||
| $1.71B-18.0% | $2.09B+26.6% | $1.65B-7.2% | $1.78B+9.9% | $1.62B-1.1% | ||
| $373.2M+142% | $154.5M-56.0% | $351.3M+17.1% | $300M+2.6% | $292.3M-24.9% | ||
| 17.9%+11.0pp | 6.9%-10.7pp | 17.6%+3.1pp | 14.4%-0.9pp | 15.3%-3.9pp | ||
| -$3M-119% | $15.4M+367% | $3.3M-15.4% | $3.9M+34.5% | $2.9M+108% | ||
| $301.3M+207% | $98M-64.9% | $279.2M+24.3% | $224.6M-1.9% | $229M-20.8% | ||
| $63M— | —— | $48M-32.6% | $71.2M+53.1% | $46.5M-4.9% | ||
| $1.22+71.8% | $0.71-38.8% | $1.16+50.6% | $0.77-15.4% | $0.91-23.5% | ||
| $1.22+71.8% | $0.71-39.3% | $1.17+51.9% | $0.77-16.3% | $0.92-23.3% | ||
| 195.8M-1.5% | 198.7M-0.1% | 198.8M+0.3% | 198.3M-0.7% | 199.7M-2.1% | ||
| 195M-1.5% | 198M-0.1% | 198.1M+0.1% | 197.9M-0.5% | 198.9M-2.1% | ||
| $15.6M-28.8% | $21.9M+164% | -$34.4M-144% | $78.9M+644% | $10.6M-22.6% | ||
| $162.1M-8.8% | $177.7M+0.7% | $176.5M+9.9% | $160.6M+6.4% | $151M-4.2% | ||
| -$68.8M+4.3% | -$71.9M+4.6% | -$75.4M+4.9% | -$79.3M-19.8% | -$66.2M-6.9% | ||
| -$3M-119% | $15.4M+367% | $3.3M-15.4% | $3.9M+34.5% | $2.9M+108% | ||
| $103.4M-12.9% | $118.7M+2.4% | $115.9M+2.3% | $113.3M+2.4% | $110.6M+1.9% | ||
| $6.3M-94.1% | $106.3M+397% | $21.4M+22.3% | $17.5M-51.4% | $36M+72.2% | ||
| $2.09B-7.0% | $2.24B+12.1% | $2B-3.7% | $2.08B+8.8% | $1.91B-5.6% | ||
| $373.2M+142% | $154.5M-56.0% | $351.3M+17.1% | $300M+2.6% | $292.3M-24.9% | ||
| $643.2M+46.7% | $438.5M-30.9% | $634.9M+11.0% | $571.8M+4.6% | $546.7M-16.2% | ||
| $643.2M+46.7% | $438.5M-30.9% | $634.9M+11.0% | $571.8M+4.6% | $546.7M-16.2% | ||
| 30.8%+11.3pp | 19.5%-12.2pp | 31.7%+4.2pp | 27.5%-1.1pp | 28.6%-3.6pp | ||
| $373.2M+142% | $154.5M-56.0% | $351.3M+17.1% | $300M+2.6% | $292.3M-24.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Zimmer Biomet Holdings's revenue?
- Zimmer Biomet Holdings (ZBH) generated $8.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Zimmer Biomet Holdings profitable?
- Zimmer Biomet Holdings reported $761.1M in net income over the trailing twelve months, a 9.1% net margin.
- What are Zimmer Biomet Holdings's profit margins?
- Gross margin is 70.0% and operating margin is 14.0%, with a 9.1% net margin.
- What is Zimmer Biomet Holdings's earnings per share?
- Zimmer Biomet Holdings's diluted EPS over the trailing twelve months is $3.86.
- Where does Zimmer Biomet Holdings's income statement data come from?
- Every line is extracted from Zimmer Biomet Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
